Patent US4728509A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4728509A Expired / Lapsed US ⏱️ 0.0 years remaining

Aqueous liquid preparation

Assignee: Senju Pharmaceutical Co Ltd
•
Filing: 1986-08-05
•
Granted: 1988-03-01
•
Expires: 2006-08-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract In the aqueous liquid preparation of this invention, which comprises a compound of the formula; ##STR1## wherein R is an alkyl having 1-6 carbon atoms, and at least one species of the solubilizers selected from the group consisting of polyvinylpyrrolidone, cyclodextrin and caffeine, the solubility of the compound in water can be heightened and the aqueous liquid prepared thereby can afford a desired stability and mitigate eye-irritation or nose-irritation.

Inventors

  • 👤 Hisayoshi Shimizu
  • 👤 Mitsuaki Oshima
  • 👤 Hideo Terayama

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 12:44
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/455; A61K47/00; A61K47/06; A61K47/22; A61K47/30; A61K47/32; A61K47/36; A61K47/40; A61P; A61P27/00; A61P27/02; A61P27/14; A61P27/16; A61P29/00; A61P37/00; A61P37/08

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 62 words
An aqueous liquid composition, which comprises a therapeutically effective amount of a compound of the formula; ##STR3## wherein R is an alkyl having 1-6 carbon atoms, and at least one solubilizer selected from the group consisting of polyvinylpyrrolidone in an amount of about 0.2-20% (W/V), cyclodextrin in an amount of about 0.2-5% (W/V), and caffeine in an amount of about 0.1-2% (W/V).
Claim 2
Dependent Claim 62 words
An aqueous liquid composition, which comprises a therapeutically effective amount of a compound of the formula; ##STR3## wherein R is an alkyl having 1-6 carbon atoms, and at least one solubilizer selected from the group consisting of polyvinylpyrrolidone in an amount of about 0.2-20% (W/V), cyclodextrin in an amount of about 0.2-5% (W/V), and caffeine in an amount of about 0.1-2% (W/V).
Claim 3
Dependent Claim 17 words
An aqueous liquid composition as claimed in claim 1, wherein the preparation is for a nasal drop.
Claim 4
Dependent Claim 17 words
An aqueous liquid composition as claimed in claim 1, wherein the preparation is for an eye drop.
Claim 5
Dependent Claim 18 words
An aqueous liquid composition as claimed in claim 1, wherein the preparation is further incorporated with boric acid.
Claim 6
Dependent Claim 14 words
An aqueous liquid composition as claimed in claim 1, wherein the solubilizer is polyvinylpyrrolidone.
Claim 7
Dependent Claim 14 words
An aqueous liquid composition as claimed in claim 1, wherein the solubilizer is cyclodextrin.
Claim 8
Dependent Claim 14 words
An aqueous liquid composition as claimed in claim 1, wherein the solubilizer is caffeine.
Claim 9
Dependent Claim 15 words
An aqueous liquid composition as claimed in claim 1, wherein the compound is 2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid.
Claim 10
Dependent Claim 21 words
An aqueous liquid composition as claimed in claim 5 wherein the polyvinylpyrrolidone is present in an amount of about 0.5-15% (W/V).
Claim 11
Dependent Claim 21 words
An aqueous liquid composition as claimed in claim 5 wherein the polyvinylpyrrolidone is present in an amount of about 10-10% (W/V).
Claim 12
Dependent Claim 21 words
An aqueous liquid composition as claimed in claim 6 wherein the cyclodextrin is present in an amount of about 0.5-2% (W/V).
Claim 13
Dependent Claim 21 words
An aqueous liquid composition as claimed in claim 7 wherein the caffeine is present in an amount of about 0.2-1.0% (W/V).

References Cited (Backward Citations)

DD7498A1 Cited
US3927205A Cited
US4143042A Cited
JPS54115398A Cited
US4344968A Cited
EP0082921A1 Cited
EP0094157A1 Cited
US4539326A Cited
EP0105635A2 Cited
EP0119737A2 Cited
EP0191568A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-03-01 1991-08-31 1992-03-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-03-01 1995-08-31 1996-03-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-03-01 1999-08-31 2000-03-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag